Anika Therapeutics Ownership | Who Owns Anika Therapeutics?

Overview RevenueFinancials Chart Transcripts

Anika Therapeutics Ownership Summary

Anika Therapeutics is owned by 88.66% institutional investors, 3.42% insiders, and 7.92% retail investors. Trigran investments is the largest institutional shareholder, holding 14.53% of ANIK shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.00% of its assets in Anika Therapeutics shares.

ANIK Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Anika Therapeutics	88.66%	3.42%	7.92%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Medical Device Stocks	53.39%	8.20%	38.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Trigran investments	2.14M	14.53%	$54.11M
Blackrock	1.61M	10.93%	$40.70M
Caligan partners lp	1.44M	9.77%	$36.37M
Vanguard group	790.14K	5.38%	$20.01M
Dimensional fund advisors lp	749.28K	5.10%	$18.98M
Renaissance	598.23K	4.07%	$15.15M
Morgan stanley	501.99K	3.42%	$12.72M
Boothbay fund management	501.95K	3.42%	$12.71M
Acadian asset management	442.94K	3.01%	$11.22M
Geode capital management	341.07K	2.32%	$8.64M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Caligan partners lp	1.44M	8.50%	$36.37M
Trigran investments	2.14M	5.66%	$54.11M
Stonepine capital management	165.40K	3.82%	$4.19M
Meros investment management, lp	212.71K	2.55%	$5.39M
Alta fundamental advisers	296.08K	2.38%	$7.50M
Capital management corp /va	328.62K	1.67%	$8.32M
Diker management	56.24K	1.21%	$1.42M
Ironwood investment management	28.70K	0.39%	$727.07K
Boothbay fund management	501.95K	0.30%	$12.71M
Riverwater partners	15.96K	0.30%	$404.24K

Top Buyers

Holder	Shares	% Assets	Change
Segall bryant & hamill	107.00K	0.05%	107.00K
Stonepine capital management	165.40K	3.82%	104.45K
Globeflex capital l p	98.00K	0.26%	65.86K
Trigran investments	2.14M	5.66%	63.81K
Blackrock	1.61M	0.00%	45.79K

Top Sellers

Holder	Shares	% Assets	Change
Morgan stanley	501.99K	0.00%	-199.74K
Nuveen asset management	100.08K	0.00%	-96.10K
Millennium management	30.71K	0.00%	-85.38K
Dimensional fund advisors lp	749.28K	0.01%	-60.47K
Virtus investment advisers	-	-	-45.58K

New Positions

Holder	Shares	% Assets	Change	Value
Segall bryant & hamill	107.00K	0.05%	107.00K	$2.71M
Verition fund management	11.71K	0.00%	11.71K	$296.61K
Voya investment management	9.90K	0.00%	9.90K	$250.84K
Mirae asset global etfs	8.13K	0.00%	8.13K	$206.06K
Corebridge financial	7.88K	0.00%	7.88K	$199.57K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-3.00
Covestor	-24.00
Quarry lp	-29.00
Simplex trading	-104.00
Metropolitan life insurance co/ny	-831.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	123	6.96%	13,093,709	-1.09%	88	1.11%	49	-2.00%	48	-
Jun 30, 2024	113	-6.61%	13,237,819	-1.18%	90	1.08%	49	-14.04%	47	14.63%
Mar 31, 2024	121	3.42%	13,396,464	1.35%	91	1.12%	57	-6.56%	41	2.50%
Dec 31, 2023	117	-0.85%	13,218,442	1.65%	90	1.14%	61	7.02%	40	-11.11%
Sep 30, 2023	118	0.85%	13,003,870	-0.51%	88	1.12%	57	1.79%	45	25.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	439.41K	3.00%	-
iShares Russell 2000 ETF	375.49K	2.56%	-784.00
Vanguard Institutional Extnd Mkt Idx Tr	255.94K	1.75%	-1.26K
CMC SMID	196.52K	1.33%	-7.22K
Fidelity Small Cap Index	147.57K	1.00%	-5.08K
Franklin Mutual Small-Mid Cap Val A	120.97K	0.83%	-
DFA US Targeted Value I	118.24K	0.80%	-3.76K
DFA US Micro Cap I	112.33K	0.76%	-
iShares Russell 2000 Value ETF	104.42K	0.71%	134.00
State St Russell Sm/Mid Cp® Indx NL Cl C	94.66K	0.65%	-2.90K

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	-	-
2024 Q2	-	-
2024 Q1	-	-
2023 Q4	-	-
2023 Q3	-	-

ANIK Ownership FAQ

Who Owns Anika Therapeutics?

Anika Therapeutics shareholders are primarily institutional investors at 88.66%, followed by 3.42% insiders and 7.92% retail investors. The average institutional ownership in Anika Therapeutics's industry, Medical Device Stocks, is 53.39%, which Anika Therapeutics exceeds.

Who owns the most shares of Anika Therapeutics?

Anika Therapeutics’s largest shareholders are Trigran investments (2.14M shares, 14.53%), Blackrock (1.61M shares, 10.93%), and Caligan partners lp (1.44M shares, 9.77%). Together, they hold 35.24% of Anika Therapeutics’s total shares outstanding.

Does Blackrock own Anika Therapeutics?

Yes, BlackRock owns 10.93% of Anika Therapeutics, totaling 1.61M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 40.7M$. In the last quarter, BlackRock increased its holdings by 45.79K shares, a 2.93% change.

Who is Anika Therapeutics’s biggest shareholder by percentage of total assets invested?

Caligan partners lp is Anika Therapeutics’s biggest shareholder by percentage of total assets invested, with 8.50% of its assets in 1.44M Anika Therapeutics shares, valued at 36.37M$.

Who is the top mutual fund holder of Anika Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Anika Therapeutics shares, with 3.00% of its total shares outstanding invested in 439.41K Anika Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools